NCT07256015 2025-12-01Deucravacitinib for Patients With Moderate/Severe Psoriasis: A Real-Life Experience in ItalyBristol-Myers SquibbRecruiting200 enrolled
NCT06952465 2025-05-01A Study Comparing the Risk of Serious Infections and Malignancies With Deucravacitinib or Biologics in Japanese Patients With PsoriasisBristol-Myers SquibbActive not recruiting2,000 enrolled